Reproductive medicine and biology · 2026
Caffeine Supplementation Enhances Aged Human Oocyte Quality and Embryo Development in In Vitro Fertilization: A Retrospective Paired Study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ha Jinkyeong, Kim Soyoung, Jang Hyunmee, Ko Yoo Ra, Han Seyul, Lee Woo Sik, Eum Jin Hee
Аннотация
PURPOSE: To evaluate whether in vitro caffeine supplementation can improve spindle integrity, embryo development, and clinical outcomes in IVF.
METHODS: This retrospective paired-cohort study included 704 women aged ≥ 35 years who underwent two ICSI cycles (one caffeine-supplemented and one non-caffeine) within 12 months. Oocytes in caffeine cycles were exposed to 1.25 mM caffeine for 4 h before fertilization. Outcomes included spindle positioning, embryo quality, blastocyst development and euploidy rates, and neonatal outcomes from 20 women (24 neonates). Paired comparisons were performed using the Wilcoxon signed-rank and McNemar's tests.
RESULTS: Caffeine cycles showed higher rates of normal spindle positioning (80.2% vs. 61.2%, p < 0.001), high-quality cleavage embryos (63.2% vs. 53.6%, p < 0.001), high-quality blastocysts (39.2% vs. 26.1%, p < 0.001), and euploid embryos (22.9% vs. 10.9%, p = 0.002) than non-caffeine cycles. The fertilization rates were similar between the groups (81.4% vs. 80.8%, p = 0.628). Clinical pregnancy rate was 39.1%, and neonatal outcomes were reassuring.
CONCLUSIONS: Short-term in vitro caffeine exposure may enhance oocyte and embryo competence in older women undergoing IVF, especially those with prior IVF failures. These findings support caffeine as a simple, practical laboratory intervention. Prospective multicenter studies are warranted to confirm efficacy and safety.
METHODS: This retrospective paired-cohort study included 704 women aged ≥ 35 years who underwent two ICSI cycles (one caffeine-supplemented and one non-caffeine) within 12 months. Oocytes in caffeine cycles were exposed to 1.25 mM caffeine for 4 h before fertilization. Outcomes included spindle positioning, embryo quality, blastocyst development and euploidy rates, and neonatal outcomes from 20 women (24 neonates). Paired comparisons were performed using the Wilcoxon signed-rank and McNemar's tests.
RESULTS: Caffeine cycles showed higher rates of normal spindle positioning (80.2% vs. 61.2%, p < 0.001), high-quality cleavage embryos (63.2% vs. 53.6%, p < 0.001), high-quality blastocysts (39.2% vs. 26.1%, p < 0.001), and euploid embryos (22.9% vs. 10.9%, p = 0.002) than non-caffeine cycles. The fertilization rates were similar between the groups (81.4% vs. 80.8%, p = 0.628). Clinical pregnancy rate was 39.1%, and neonatal outcomes were reassuring.
CONCLUSIONS: Short-term in vitro caffeine exposure may enhance oocyte and embryo competence in older women undergoing IVF, especially those with prior IVF failures. These findings support caffeine as a simple, practical laboratory intervention. Prospective multicenter studies are warranted to confirm efficacy and safety.